Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

April 19, 2015 4:28 AM ET


Company Overview of DUSA Pharmaceuticals Inc.

Executive Profile

Alexander Whitman Casdin

Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee, Ignyta, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 3 different industries.

See Board Relationships


Mr. Alexander Whitman Casdin, also known as Alex, has been an Executive Advisor of Ignyta, Inc., since December 2012 and its Director since October 31, 2013. Mr. Casdin served as the Chief Financial Officer at Sophiris Bio, Inc. from October 10, 2011 to September 14, 2012. He served as Vice President, Finance of Amylin Pharmaceuticals, from 2009 to 2011, overseeing Financial Planning and Analysis, Investor Relations and Treasury. He joined it in 2009. Prior to founding ...

Corporate Headquarters

25 Upton Drive
Wilmington, Massachusetts 01887

United States

Phone: 978-657-7500
Fax: 978-657-9193

Board Members Memberships

Former Director, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee


Brown University
MBA 1996
Columbia Business School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$54,583
Total Calculated Compensation$54,583

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DUSA Pharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at